Back to Search Start Over

Connect Biopharma Holdings Ltd Announces Topline Data from Global Phase 2b Trial of Rademikibart in Patients with ModeratetoSevere Asthma - Final

Source :
Fair Disclosure Wire. December 12, 2023
Publication Year :
2023

Abstract

Presentation OPERATOR: Okay. Yes, yes, good morning and welcome to the Connect Biopharma Conference Call. (Operator Instructions). Please be advised that this call is being recorded at the company's request [...]

Details

Language :
English
Database :
Gale General OneFile
Journal :
Fair Disclosure Wire
Publication Type :
Transcript
Accession number :
edsgcl.777478311